Qianjin vinesu is on fire! Qianjin Pharmaceutical and many other companies quickly clarified_ Oriental Fortune Net Post date May 17, 2022 — 09:35 Post Lock Read More Qianjin vinesu is on fire! Qianjin Pharmaceutical and many other companies quickly clarified – yqqlm Post date May 17, 2022 — 09:34 Post Lock Read More The hype is crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: say you have it and you will have it – yqqlm Post date May 17, 2022 — 09:33 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: If you have it, you will have every Jingwang Post date May 17, 2022 — 04:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: if you have it, you will have it Post date May 17, 2022 — 02:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm Post date May 17, 2022 — 02:06 Post Lock Read More Qianjin Pharmaceutical does not have Qianjin Tensudo to clarify the connection! Note that the inhibition data of 15,000 times the risk is only the result of in vitro experiments Post date May 16, 2022 — 23:09 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Inhibit virus 15393 times! The new crown treatment drug has made a major discovery, how effective is it? -News Channel-Hexun.com Post date May 15, 2022 — 08:35 Post Lock Read More Hanyu Pharmaceutical: Our company's new crown nasal spray project has only taken half a year since it was launched, and the preclinical process research has been completed. Post date May 12, 2022 — 21:23 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Enhua Pharmaceutical: Currently the company exclusively produces and sells lithium carbonate sustained-release tablets in the domestic market Post date April 29, 2022 — 08:27 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development. Post date April 24, 2022 — 22:33 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development Post date April 24, 2022 — 22:17 Post Lock Read More Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Qianjin vinesu is on fire! Qianjin Pharmaceutical and many other companies quickly clarified – yqqlm Post date May 17, 2022 — 09:34 Post Lock Read More The hype is crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: say you have it and you will have it – yqqlm Post date May 17, 2022 — 09:33 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: If you have it, you will have every Jingwang Post date May 17, 2022 — 04:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: if you have it, you will have it Post date May 17, 2022 — 02:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm Post date May 17, 2022 — 02:06 Post Lock Read More Qianjin Pharmaceutical does not have Qianjin Tensudo to clarify the connection! Note that the inhibition data of 15,000 times the risk is only the result of in vitro experiments Post date May 16, 2022 — 23:09 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Inhibit virus 15393 times! The new crown treatment drug has made a major discovery, how effective is it? -News Channel-Hexun.com Post date May 15, 2022 — 08:35 Post Lock Read More Hanyu Pharmaceutical: Our company's new crown nasal spray project has only taken half a year since it was launched, and the preclinical process research has been completed. Post date May 12, 2022 — 21:23 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Enhua Pharmaceutical: Currently the company exclusively produces and sells lithium carbonate sustained-release tablets in the domestic market Post date April 29, 2022 — 08:27 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development. Post date April 24, 2022 — 22:33 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development Post date April 24, 2022 — 22:17 Post Lock Read More Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The hype is crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: say you have it and you will have it – yqqlm Post date May 17, 2022 — 09:33 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: If you have it, you will have every Jingwang Post date May 17, 2022 — 04:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: if you have it, you will have it Post date May 17, 2022 — 02:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm Post date May 17, 2022 — 02:06 Post Lock Read More Qianjin Pharmaceutical does not have Qianjin Tensudo to clarify the connection! Note that the inhibition data of 15,000 times the risk is only the result of in vitro experiments Post date May 16, 2022 — 23:09 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Inhibit virus 15393 times! The new crown treatment drug has made a major discovery, how effective is it? -News Channel-Hexun.com Post date May 15, 2022 — 08:35 Post Lock Read More Hanyu Pharmaceutical: Our company's new crown nasal spray project has only taken half a year since it was launched, and the preclinical process research has been completed. Post date May 12, 2022 — 21:23 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Enhua Pharmaceutical: Currently the company exclusively produces and sells lithium carbonate sustained-release tablets in the domestic market Post date April 29, 2022 — 08:27 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development. Post date April 24, 2022 — 22:33 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development Post date April 24, 2022 — 22:17 Post Lock Read More Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: If you have it, you will have every Jingwang Post date May 17, 2022 — 04:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: if you have it, you will have it Post date May 17, 2022 — 02:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm Post date May 17, 2022 — 02:06 Post Lock Read More Qianjin Pharmaceutical does not have Qianjin Tensudo to clarify the connection! Note that the inhibition data of 15,000 times the risk is only the result of in vitro experiments Post date May 16, 2022 — 23:09 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Inhibit virus 15393 times! The new crown treatment drug has made a major discovery, how effective is it? -News Channel-Hexun.com Post date May 15, 2022 — 08:35 Post Lock Read More Hanyu Pharmaceutical: Our company's new crown nasal spray project has only taken half a year since it was launched, and the preclinical process research has been completed. Post date May 12, 2022 — 21:23 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Enhua Pharmaceutical: Currently the company exclusively produces and sells lithium carbonate sustained-release tablets in the domestic market Post date April 29, 2022 — 08:27 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development. Post date April 24, 2022 — 22:33 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development Post date April 24, 2022 — 22:17 Post Lock Read More Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: if you have it, you will have it Post date May 17, 2022 — 02:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm Post date May 17, 2022 — 02:06 Post Lock Read More Qianjin Pharmaceutical does not have Qianjin Tensudo to clarify the connection! Note that the inhibition data of 15,000 times the risk is only the result of in vitro experiments Post date May 16, 2022 — 23:09 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Inhibit virus 15393 times! The new crown treatment drug has made a major discovery, how effective is it? -News Channel-Hexun.com Post date May 15, 2022 — 08:35 Post Lock Read More Hanyu Pharmaceutical: Our company's new crown nasal spray project has only taken half a year since it was launched, and the preclinical process research has been completed. Post date May 12, 2022 — 21:23 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Enhua Pharmaceutical: Currently the company exclusively produces and sells lithium carbonate sustained-release tablets in the domestic market Post date April 29, 2022 — 08:27 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development. Post date April 24, 2022 — 22:33 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development Post date April 24, 2022 — 22:17 Post Lock Read More Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm Post date May 17, 2022 — 02:06 Post Lock Read More Qianjin Pharmaceutical does not have Qianjin Tensudo to clarify the connection! Note that the inhibition data of 15,000 times the risk is only the result of in vitro experiments Post date May 16, 2022 — 23:09 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Inhibit virus 15393 times! The new crown treatment drug has made a major discovery, how effective is it? -News Channel-Hexun.com Post date May 15, 2022 — 08:35 Post Lock Read More Hanyu Pharmaceutical: Our company's new crown nasal spray project has only taken half a year since it was launched, and the preclinical process research has been completed. Post date May 12, 2022 — 21:23 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Enhua Pharmaceutical: Currently the company exclusively produces and sells lithium carbonate sustained-release tablets in the domestic market Post date April 29, 2022 — 08:27 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development. Post date April 24, 2022 — 22:33 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development Post date April 24, 2022 — 22:17 Post Lock Read More Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Qianjin Pharmaceutical does not have Qianjin Tensudo to clarify the connection! Note that the inhibition data of 15,000 times the risk is only the result of in vitro experiments Post date May 16, 2022 — 23:09 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Inhibit virus 15393 times! The new crown treatment drug has made a major discovery, how effective is it? -News Channel-Hexun.com Post date May 15, 2022 — 08:35 Post Lock Read More Hanyu Pharmaceutical: Our company's new crown nasal spray project has only taken half a year since it was launched, and the preclinical process research has been completed. Post date May 12, 2022 — 21:23 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Enhua Pharmaceutical: Currently the company exclusively produces and sells lithium carbonate sustained-release tablets in the domestic market Post date April 29, 2022 — 08:27 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development. Post date April 24, 2022 — 22:33 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development Post date April 24, 2022 — 22:17 Post Lock Read More Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Inhibit virus 15393 times! The new crown treatment drug has made a major discovery, how effective is it? -News Channel-Hexun.com Post date May 15, 2022 — 08:35 Post Lock Read More Hanyu Pharmaceutical: Our company's new crown nasal spray project has only taken half a year since it was launched, and the preclinical process research has been completed. Post date May 12, 2022 — 21:23 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Enhua Pharmaceutical: Currently the company exclusively produces and sells lithium carbonate sustained-release tablets in the domestic market Post date April 29, 2022 — 08:27 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development. Post date April 24, 2022 — 22:33 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development Post date April 24, 2022 — 22:17 Post Lock Read More Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Inhibit virus 15393 times! The new crown treatment drug has made a major discovery, how effective is it? -News Channel-Hexun.com Post date May 15, 2022 — 08:35 Post Lock Read More Hanyu Pharmaceutical: Our company's new crown nasal spray project has only taken half a year since it was launched, and the preclinical process research has been completed. Post date May 12, 2022 — 21:23 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Enhua Pharmaceutical: Currently the company exclusively produces and sells lithium carbonate sustained-release tablets in the domestic market Post date April 29, 2022 — 08:27 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development. Post date April 24, 2022 — 22:33 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development Post date April 24, 2022 — 22:17 Post Lock Read More Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Hanyu Pharmaceutical: Our company's new crown nasal spray project has only taken half a year since it was launched, and the preclinical process research has been completed. Post date May 12, 2022 — 21:23 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Enhua Pharmaceutical: Currently the company exclusively produces and sells lithium carbonate sustained-release tablets in the domestic market Post date April 29, 2022 — 08:27 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development. Post date April 24, 2022 — 22:33 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development Post date April 24, 2022 — 22:17 Post Lock Read More Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
[Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Enhua Pharmaceutical: Currently the company exclusively produces and sells lithium carbonate sustained-release tablets in the domestic market Post date April 29, 2022 — 08:27 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development. Post date April 24, 2022 — 22:33 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development Post date April 24, 2022 — 22:17 Post Lock Read More Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Enhua Pharmaceutical: Currently the company exclusively produces and sells lithium carbonate sustained-release tablets in the domestic market Post date April 29, 2022 — 08:27 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development. Post date April 24, 2022 — 22:33 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development Post date April 24, 2022 — 22:17 Post Lock Read More Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development. Post date April 24, 2022 — 22:33 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development Post date April 24, 2022 — 22:17 Post Lock Read More Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development. Post date April 24, 2022 — 22:33 Post Lock Read More Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development Post date April 24, 2022 — 22:17 Post Lock Read More Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development Post date April 24, 2022 — 22:17 Post Lock Read More Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Hengrui Medicine's net profit in 2021 drops by nearly 30%, R&D investment of 6.2 billion yuan hits a new high Post date April 24, 2022 — 21:35 Post Lock Read More Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm Post date April 22, 2022 — 22:03 Post Lock Read More Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Last year, the gross profit margin of liver disease drugs dropped. Pien Tze Huang started clinical research on the treatment of liver cancer. Post date April 17, 2022 — 23:41 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and he responded urgently on the weekend! Stocks Financial World Post date April 17, 2022 — 13:00 Post Lock Read More Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Crazy swipe! Dr. Clove shot late at night: Don't take this medicine to prevent the new crown! It was hit by Wang Sicong's hammer just before, and an emergency response was made on the weekend Post date April 17, 2022 — 13:00 Post Lock Read More
Caishen.CoCaishen.Co